Is PAVM or CTSO more profitable?

Cytosorbents has a net margin of -31.85% compared to PAVmed's net margin of -21,914.12%. PAVmed's return on equity of -146.19% beat Cytosorbents' return on equity. Company Net Margins Return on Equity Return on Assets PAVmed -21,914.12% -146.19% -18.39% Cytosorbents -31.85% -235.57% -37.88%

Which has preferable valuation & earnings, PAVM or LFWD?

PAVmed has higher earnings, but lower revenue than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PAVmed $85K 66.91 $400K -$37.40 N/A Lifeward $20.92M 1.08 -$19.91M -$19.66 N/A

Is PAVM or LFWD more profitable?

Lifeward has a net margin of -123.66% compared to PAVmed's net margin of -21,914.12%. PAVmed's return on equity of -146.19% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets PAVmed -21,914.12% -146.19% -18.39% Lifeward -123.66% -243.14% -97.39%

Do analysts recommend PAVM or RVP?

PAVmed presently has a consensus target price of $56.00, suggesting a potential upside of 880.74%. Given PAVmed's stronger consensus rating and higher possible upside, analysts clearly believe PAVmed is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PAVmed 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts prefer MODD or PAVM?

PAVmed has a consensus price target of $56.00, indicating a potential upside of 880.74%. Given PAVmed's stronger consensus rating and higher possible upside, analysts plainly believe PAVmed is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 PAVmed 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is MODD or PAVM more profitable?

Modular Medical has a net margin of 0.00% compared to PAVmed's net margin of -21,914.12%. PAVmed's return on equity of -146.19% beat Modular Medical's return on equity. Company Net Margins Return on Equity Return on Assets Modular Medical N/A -245.85% -190.80% PAVmed -21,914.12% -146.19% -18.39%

Do analysts recommend TMDIF or PAVM?

PAVmed has a consensus target price of $56.00, suggesting a potential upside of 880.74%. Given PAVmed's stronger consensus rating and higher probable upside, analysts plainly believe PAVmed is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 PAVmed 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better valuation and earnings, TMDIF or PAVM?

Titan Medical has higher revenue and earnings than PAVmed. PAVmed is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Titan Medical $17.63M 1.16 $6.95M $0.05 3.60 PAVmed $85K 66.91 $400K -$37.40 N/A

Is TMDIF or PAVM more profitable?

Titan Medical has a net margin of 0.00% compared to PAVmed's net margin of -21,914.12%. Titan Medical's return on equity of -82.31% beat PAVmed's return on equity. Company Net Margins Return on Equity Return on Assets Titan Medical N/A -82.31% -51.47% PAVmed -21,914.12% -146.19% -18.39%

PAVmed (PAVM) Competitors

$5.71 0.00 (0.00%)

Closing price 07/2/2026 03:59 PM Eastern

Extended Trading

$5.58 -0.13 (-2.28%)

As of 07/2/2026 06:06 PM Eastern

Compare

PAVM vs. CTSO, LFWD, RVP, MODD, and TMDIF

Should you buy PAVmed stock or one of its competitors? MarketBeat compares PAVmed with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with PAVmed include Cytosorbents (CTSO), Lifeward (LFWD), Retractable Technologies (RVP), Modular Medical (MODD), and Titan Medical (TMDIF). These companies are all part of the "medical equipment" industry.

How does PAVmed compare to Cytosorbents?

PAVmed (NASDAQ:PAVM) and Cytosorbents (NASDAQ:CTSO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations.

PAVmed has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market. Comparatively, Cytosorbents has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market.

Cytosorbents has a net margin of -31.85% compared to PAVmed's net margin of -21,914.12%. PAVmed's return on equity of -146.19% beat Cytosorbents' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PAVmed	-21,914.12%	-146.19%	-18.39%
Cytosorbents	-31.85%	-235.57%	-37.88%

In the previous week, PAVmed's average media sentiment score of 0.00 equaled Cytosorbents'average media sentiment score.

Company	Overall Sentiment
PAVmed	Neutral
Cytosorbents	Neutral

19.9% of PAVmed shares are held by institutional investors. Comparatively, 32.9% of Cytosorbents shares are held by institutional investors. 13.4% of PAVmed shares are held by company insiders. Comparatively, 7.8% of Cytosorbents shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

PAVmed has higher earnings, but lower revenue than Cytosorbents. Cytosorbents is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PAVmed	$85K	66.91	$400K	-$37.40	N/A
Cytosorbents	$37.06M	0.66	-$8.20M	-$0.19	N/A

PAVmed currently has a consensus price target of $56.00, suggesting a potential upside of 880.74%. Cytosorbents has a consensus price target of $5.38, suggesting a potential upside of 1,278.21%. Given Cytosorbents' higher probable upside, analysts clearly believe Cytosorbents is more favorable than PAVmed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PAVmed	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cytosorbents	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

PAVmed and Cytosorbents tied by winning 6 of the 12 factors compared between the two stocks.

How does PAVmed compare to Lifeward?

PAVmed (NASDAQ:PAVM) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership.

19.9% of PAVmed shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 13.4% of PAVmed shares are held by company insiders. Comparatively, 1.5% of Lifeward shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

PAVmed has a beta of 0.54, indicating that its share price is 46% less volatile than the broader market. Comparatively, Lifeward has a beta of 0.37, indicating that its share price is 63% less volatile than the broader market.

PAVmed currently has a consensus price target of $56.00, suggesting a potential upside of 880.74%. Lifeward has a consensus price target of $10.00, suggesting a potential upside of 24.69%. Given PAVmed's stronger consensus rating and higher probable upside, research analysts plainly believe PAVmed is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PAVmed	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Lifeward	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

Lifeward has a net margin of -123.66% compared to PAVmed's net margin of -21,914.12%. PAVmed's return on equity of -146.19% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PAVmed	-21,914.12%	-146.19%	-18.39%
Lifeward	-123.66%	-243.14%	-97.39%

In the previous week, PAVmed's average media sentiment score of 0.00 equaled Lifeward'saverage media sentiment score.

Company	Overall Sentiment
PAVmed	Neutral
Lifeward	Neutral

PAVmed has higher earnings, but lower revenue than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PAVmed	$85K	66.91	$400K	-$37.40	N/A
Lifeward	$20.92M	1.08	-$19.91M	-$19.66	N/A

Summary

PAVmed beats Lifeward on 9 of the 13 factors compared between the two stocks.

How does PAVmed compare to Retractable Technologies?

PAVmed (NASDAQ:PAVM) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.

PAVmed has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market.

Retractable Technologies has a net margin of -41.11% compared to PAVmed's net margin of -21,914.12%. Retractable Technologies' return on equity of -17.15% beat PAVmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PAVmed	-21,914.12%	-146.19%	-18.39%
Retractable Technologies	-41.11%	-17.15%	-9.33%

In the previous week, Retractable Technologies had 1 more articles in the media than PAVmed. MarketBeat recorded 1 mentions for Retractable Technologies and 0 mentions for PAVmed. PAVmed's average media sentiment score of 0.00 equaled Retractable Technologies'average media sentiment score.

Company	Overall Sentiment
PAVmed	Neutral
Retractable Technologies	Neutral

PAVmed has higher earnings, but lower revenue than Retractable Technologies. Retractable Technologies is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PAVmed	$85K	66.91	$400K	-$37.40	N/A
Retractable Technologies	$37.15M	0.59	-$7.01M	-$0.21	N/A

19.9% of PAVmed shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 13.4% of PAVmed shares are held by company insiders. Comparatively, 59.5% of Retractable Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

PAVmed presently has a consensus target price of $56.00, suggesting a potential upside of 880.74%. Given PAVmed's stronger consensus rating and higher possible upside, analysts clearly believe PAVmed is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PAVmed	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Retractable Technologies beats PAVmed on 8 of the 15 factors compared between the two stocks.

How does PAVmed compare to Modular Medical?

Modular Medical (NASDAQ:MODD) and PAVmed (NASDAQ:PAVM) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, media sentiment, valuation, earnings and profitability.

In the previous week, Modular Medical had 2 more articles in the media than PAVmed. MarketBeat recorded 2 mentions for Modular Medical and 0 mentions for PAVmed. Modular Medical's average media sentiment score of 0.00 equaled PAVmed'saverage media sentiment score.

Company	Overall Sentiment
Modular Medical	Neutral
PAVmed	Neutral

Modular Medical has a net margin of 0.00% compared to PAVmed's net margin of -21,914.12%. PAVmed's return on equity of -146.19% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-245.85%	-190.80%
PAVmed	-21,914.12%	-146.19%	-18.39%

27.5% of Modular Medical shares are held by institutional investors. Comparatively, 19.9% of PAVmed shares are held by institutional investors. 7.1% of Modular Medical shares are held by company insiders. Comparatively, 13.4% of PAVmed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

PAVmed has a consensus price target of $56.00, indicating a potential upside of 880.74%. Given PAVmed's stronger consensus rating and higher possible upside, analysts plainly believe PAVmed is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
PAVmed	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

PAVmed has higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$18.82M	-$14.71	N/A
PAVmed	$85K	66.91	$400K	-$37.40	N/A

Modular Medical has a beta of 0.32, indicating that its stock price is 68% less volatile than the broader market. Comparatively, PAVmed has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market.

Summary

PAVmed beats Modular Medical on 10 of the 14 factors compared between the two stocks.

How does PAVmed compare to Titan Medical?

Titan Medical (NASDAQ:TMDIF) and PAVmed (NASDAQ:PAVM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and media sentiment.

PAVmed has a consensus target price of $56.00, suggesting a potential upside of 880.74%. Given PAVmed's stronger consensus rating and higher probable upside, analysts plainly believe PAVmed is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
PAVmed	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Titan Medical's average media sentiment score of 0.00 equaled PAVmed'saverage media sentiment score.

Company	Overall Sentiment
Titan Medical	Neutral
PAVmed	Neutral

Titan Medical has a net margin of 0.00% compared to PAVmed's net margin of -21,914.12%. Titan Medical's return on equity of -82.31% beat PAVmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
PAVmed	-21,914.12%	-146.19%	-18.39%

Titan Medical has higher revenue and earnings than PAVmed. PAVmed is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	1.16	$6.95M	$0.05	3.60
PAVmed	$85K	66.91	$400K	-$37.40	N/A

0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 19.9% of PAVmed shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by company insiders. Comparatively, 13.4% of PAVmed shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, PAVmed has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market.

Summary

Titan Medical and PAVmed tied by winning 7 of the 14 factors compared between the two stocks.

Get PAVmed News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PAVM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PAVM vs. The Competition

Export

Metric	PAVmed	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$5.69M	$7.57B	$7.16B	$12.48B
Dividend Yield	N/A	1.32%	2.66%	6.52%
P/E Ratio	-0.15	52.12	28.02	24.70
Price / Sales	66.91	49.46	540.37	99.49
Price / Cash	N/A	26.72	49.26	57.09
Price / Book	-2.36	7.48	10.96	6.46
Net Income	$400K	$159.19M	$3.57B	$337.01M
7 Day Performance	13.07%	-0.39%	2.12%	1.69%
1 Month Performance	4.77%	-0.43%	5.25%	3.81%
1 Year Performance	-68.12%	3.14%	33.29%	23.90%

PAVmed Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PAVM PAVmed	2.092 of 5 stars	$5.71 flat	$56.00 +880.7%	-68.1%	$5.69M	$85K	N/A	90	Gap Up
CTSO Cytosorbents	2.4852 of 5 stars	$0.37 -2.0%	$5.38 +1,337.2%	-62.5%	$23.50M	$37.06M	N/A	220
LFWD Lifeward	1.8538 of 5 stars	$7.80 +9.2%	$10.00 +28.3%	-0.4%	$21.90M	$22.03M	N/A	60	Gap Down
RVP Retractable Technologies	N/A	$0.72 +2.1%	N/A	+12.2%	$21.56M	$37.15M	N/A	240
MODD Modular Medical	0.5627 of 5 stars	$4.50 -7.8%	N/A	-79.0%	$20.97M	N/A	N/A	20	Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PAVM) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PAVmed (PAVM) Competitors

PAVM vs. CTSO, LFWD, RVP, MODD, and TMDIF

How does PAVmed compare to Cytosorbents?

Summary

How does PAVmed compare to Lifeward?

Summary

How does PAVmed compare to Retractable Technologies?

Summary

How does PAVmed compare to Modular Medical?

Summary

How does PAVmed compare to Titan Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PAVM vs. The Competition

PAVmed Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

PAVmed (PAVM) Competitors

PAVM vs. CTSO, LFWD, RVP, MODD, and TMDIF

How does PAVmed compare to Cytosorbents?

Which has more risk & volatility, PAVM or CTSO?

Is PAVM or CTSO more profitable?

Does the media favor PAVM or CTSO?

Do institutionals and insiders hold more shares of PAVM or CTSO?

Which has stronger valuation & earnings, PAVM or CTSO?

Do analysts rate PAVM or CTSO?

Summary

How does PAVmed compare to Lifeward?

Do institutionals & insiders hold more shares of PAVM or LFWD?

Which has more risk and volatility, PAVM or LFWD?

Do analysts rate PAVM or LFWD?

Is PAVM or LFWD more profitable?

Does the media prefer PAVM or LFWD?

Which has preferable valuation & earnings, PAVM or LFWD?

Summary

How does PAVmed compare to Retractable Technologies?

Which has more volatility and risk, PAVM or RVP?

Is PAVM or RVP more profitable?

Does the media prefer PAVM or RVP?

Which has stronger earnings and valuation, PAVM or RVP?

Do insiders & institutionals hold more shares of PAVM or RVP?

Do analysts recommend PAVM or RVP?

Summary

How does PAVmed compare to Modular Medical?

Does the media refer more to MODD or PAVM?

Is MODD or PAVM more profitable?

Do insiders and institutionals have more ownership in MODD or PAVM?

Do analysts prefer MODD or PAVM?

Which has preferable earnings & valuation, MODD or PAVM?

Which has more volatility and risk, MODD or PAVM?

Summary

How does PAVmed compare to Titan Medical?

Do analysts recommend TMDIF or PAVM?

Does the media favor TMDIF or PAVM?

Is TMDIF or PAVM more profitable?

Which has better valuation and earnings, TMDIF or PAVM?

Do insiders and institutionals hold more shares of TMDIF or PAVM?

Which has more volatility & risk, TMDIF or PAVM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PAVM vs. The Competition

PAVmed Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools